Vivo Capital, LLC - BIOPHARMX CORP ownership

BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 23 filers reported holding BIOPHARMX CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of BIOPHARMX CORP
ValueSharesWeighting
Q1 2019$1,419,000
-18.4%
16,128,5150.0%0.14%
-36.5%
Q4 2018$1,740,000
-43.2%
16,128,5150.0%0.22%
-28.2%
Q3 2018$3,064,000
-14.0%
16,128,5150.0%0.31%
-32.7%
Q2 2018$3,561,000
-4.4%
16,128,5150.0%0.46%
-13.1%
Q1 2018$3,726,000
+145.0%
16,128,515
+16.9%
0.53%
+62.0%
Q4 2017$1,521,000
-62.3%
13,799,944
-2.1%
0.33%
-60.0%
Q3 2017$4,032,000
-40.3%
14,096,3380.0%0.82%
-52.1%
Q2 2017$6,752,000
+4.3%
14,096,338
+10.0%
1.70%
-10.7%
Q1 2017$6,471,000
+35.0%
12,814,2860.0%1.90%
+20.6%
Q4 2016$4,793,00012,814,2861.58%
Other shareholders
BIOPHARMX CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 14,096,338$6,752,0001.70%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 58,027$28,0000.01%
Virtu KCG Holdings LLC 503,418$241,0000.01%
Baker Brothers Advisors 598,758$287,0000.00%
Moors & Cabot, Inc. 40,000$19,0000.00%
FRANKLIN RESOURCES INC 9,499,615$4,550,0000.00%
TWO SIGMA SECURITIES, LLC 11,385$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 323,967$155,0000.00%
GUGGENHEIM CAPITAL LLC 22,718$11,0000.00%
OPPENHEIMER & CO INC 28,000$13,0000.00%
View complete list of BIOPHARMX CORP shareholders